Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in an in vivo model

doi:10.3748/wjg.v23.i23.4200

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 23

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9347)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

502

WORD

229

HTML

4810

Figures (1-5)

347

Tables (1-3)

224

Sum=6112

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

990

Download

2245

Sum=3235

Jun 21, 2017 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (49)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Jun 21, 2017; 23(23): 4200-4210
Published online Jun 21, 2017. doi: 10.3748/wjg.v23.i23.4200

Table 3 Average value of hydrodynamic diameter (Zave) and polidispersity index of cholesteryl butyrate and dexamethasone cholesteryl butyrate-solid lipid nanoparticles formulations

Physical characterization DLS analysis	Cb	DxCb-SLN
Zave in nm	79.6	72.9
Polydispersity index	0.25	0.28

Cb: Cholesteryl butyrate; DxCb-SLN: Dexamethasone cholesteryl butyrate-solid lipid nanoparticles.

Citation: Dianzani C, Foglietta F, Ferrara B, Rosa AC, Muntoni E, Gasco P, Della Pepa C, Canaparo R, Serpe L. Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in an in vivo model. World J Gastroenterol 2017; 23(23): 4200-4210
URL: https://www.wjgnet.com/1007-9327/full/v23/i23/4200.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i23.4200